Twitter  |    LinkedIn

Benchside Dispatches: Psoriasis

Now Viewing Articles

Advancing Innovation in Dermatology is pleased to make available our collection of scholar articles, industry news, and interviews with the professionals accelerating innovation in skin health and patient care. This content is yet another way beyond our in-person and virtual events to strengthen the community of innovators we aim to build and maintain.

Sep 30, 2016
By: Advancing Innovation in Dermatology

An interview with Alice Gottlieb, MD, PhD

In the third installment of this series, Alice Gottlieb, MD, PhD, discusses psoriasis. Dr. Gottlieb is Professor of Dermatology in the Department of Dermatology at Tufts University School of Medicine. She is board certified in Dermatology, Rheumatology, and Internal Medicine. Dr. Gottlieb is recognized as one of the foremost experts in psoriasis with regard to both research and patient care.

Psoriasis is one of the most confounding diseases in dermatology. It can have severe, crippling manifestations that significantly impact patients’ quality of life—and yet, there are many patients who exhibit only a milder form of the disease for their entire lives. Some patients have serious systemic manifestations, including psoriatic arthritis and cardiovascular disease, but it is not entirely clear why only a subset of patients develop these complications.

Alice Gottlieb, MD, PhD has been at the forefront of psoriasis research and her bench and clinical discoveries have been foundational in describing the interactions of the epidermis and T-cells, thus unveiling the importance of the immune system in active disease. This ushered in biologics for the treatment of psoriasis, which has been transformative. Yet, according to Dr. Gottlieb, there are still significant research and knowledge gaps that need to be addressed to further improve the well-being of many patients.

Read full interview: Full Article sourced at the Practical Dermatology.

Download PDF